CARDIFF ONCOLOGY, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
CARDIFF ONCOLOGY, INC. (CRDF) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 37.16 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-06
- CARDIFF ONCOLOGY, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 37.16M shares, a 275.02% increase year-over-year.
- CARDIFF ONCOLOGY, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 35.67M shares, a 326.98% increase year-over-year.
- CARDIFF ONCOLOGY, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 23.34M shares, a 287.43% increase year-over-year.
- CARDIFF ONCOLOGY, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 14.49M shares, a 167.97% increase year-over-year.
- CARDIFF ONCOLOGY, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 20.87M shares, a 249.43% increase from fiscal 2019.
- CARDIFF ONCOLOGY, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 5.97M shares, a 156.37% increase from fiscal 2018.
- CARDIFF ONCOLOGY, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 2.33M shares.
- CARDIFF ONCOLOGY, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 16.98M shares, a 29.94% increase from fiscal 2012.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | 37.16M shares 10-Q · filed 2021-05-06 | 36.42M shares derived: average of 2 quarters · filed 2021-05-06 | 32.06M shares derived: average of 3 quarters · filed 2021-05-06 | 27.67M shares derived: average of 4 quarters · filed 2021-05-06 | |
| 2020-12-31 | 35.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 29.51M shares derived: average of 2 quarters · filed 2021-02-25 | 24.50M shares derived: average of 3 quarters · filed 2021-02-25 | 20.87M shares 10-K · filed 2021-02-25 | |
| 2020-09-30 | 23.34M shares 10-Q · filed 2020-11-05 | 18.92M shares derived: average of 2 quarters · filed 2020-11-05 | 15.94M shares 10-Q · filed 2020-11-05 | 14.02M shares derived: average of 4 quarters · filed 2021-05-06 | |
| 2020-06-30 | 14.49M shares 10-Q · filed 2020-08-11 | 12.20M shares 10-Q · filed 2020-08-11 | 10.92M shares derived: average of 3 quarters · filed 2021-05-06 | 9.70M shares derived: average of 4 quarters · filed 2021-05-06 | |
| 2020-03-31 | 9.91M shares 10-Q · filed 2021-05-06 | 9.91M shares 10-Q · filed 2020-05-07 | 9.13M shares derived: average of 2 quarters · filed 2021-05-06 | 8.10M shares derived: average of 3 quarters · filed 2021-05-06 | 7.42M shares derived: average of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | 8.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 7.19M shares derived: average of 2 quarters · filed 2021-02-25 | 6.60M shares derived: average of 3 quarters · filed 2021-02-25 | 5.97M shares 10-K · filed 2021-02-25 | |
| 2019-09-30 | 6.02M shares 10-Q · filed 2020-11-05 | 6.02M shares 10-K · filed 2020-02-27 | 5.72M shares derived: average of 2 quarters · filed 2020-11-05 | 5.18M shares 10-Q · filed 2020-11-05 | |
| 2019-06-30 | 5.41M shares 10-Q · filed 2020-08-11 | 4.75M shares 10-Q · filed 2020-08-11 | |||
| 2019-03-31 | 4.09M shares 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | 2.33M shares 10-K · filed 2020-02-27 | ||||
| 2014-09-30 | 18.90M shares 10-Q · filed 2014-11-06 | 18.90M shares derived: average of 2 quarters · filed 2014-11-06 | 18.90M shares 10-Q · filed 2014-11-06 | 18.90M shares derived: average of 4 quarters · filed 2014-11-06 | |
| 2014-06-30 | 18.90M shares 10-Q · filed 2014-08-07 | 18.90M shares 10-Q · filed 2014-08-07 | 18.90M shares derived: average of 3 quarters · filed 2014-08-07 | 18.64M shares derived: average of 4 quarters · filed 2014-11-06 | |
| 2014-03-31 | 18.90M shares 10-Q · filed 2014-05-12 | 18.90M shares derived: average of 2 quarters · filed 2014-05-12 | 18.56M shares derived: average of 3 quarters · filed 2014-11-06 | 17.81M shares derived: average of 4 quarters · filed 2014-11-06 | |
| 2013-12-31 | 18.90M shares 10-K · filed 2014-03-17 | 18.39M shares derived: average of 2 quarters · filed 2014-11-06 | 17.45M shares derived: average of 3 quarters · filed 2014-11-06 | 16.98M shares 10-K · filed 2014-03-17 | |
| 2013-09-30 | 17.87M shares 10-Q · filed 2014-11-06 | 16.73M shares derived: average of 2 quarters · filed 2014-11-06 | 16.33M shares 10-Q · filed 2014-11-06 | 15.92M shares derived: average of 4 quarters · filed 2014-11-06 | |
| 2013-06-30 | 15.58M shares 10-Q · filed 2014-08-07 | 15.55M shares 10-Q · filed 2014-08-07 | 15.27M shares derived: average of 3 quarters · filed 2014-08-07 | 15.00M shares derived: average of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | 15.51M shares 10-Q · filed 2014-05-12 | 15.11M shares derived: average of 2 quarters · filed 2014-05-12 | 14.80M shares derived: average of 3 quarters · filed 2014-05-12 | 14.12M shares derived: average of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | 14.72M shares 10-K · filed 2014-03-17 | 14.45M shares derived: average of 2 quarters · filed 2014-03-17 | 13.66M shares derived: average of 3 quarters · filed 2014-03-17 | 13.07M shares 10-K · filed 2014-03-17 | |
| 2012-09-30 | 14.18M shares 10-K · filed 2014-03-17 | 13.13M shares derived: average of 2 quarters · filed 2014-03-17 | 12.51M shares 10-Q · filed 2013-11-14 | 11.98M shares derived: average of 4 quarters · filed 2014-03-17 | |
| 2012-06-30 | 12.09M shares 10-K · filed 2014-03-17 | 11.54M shares 10-Q · filed 2013-08-14 | 11.24M shares derived: average of 3 quarters · filed 2014-03-17 | 10.94M shares derived: average of 4 quarters · filed 2014-03-17 | |
| 2012-03-31 | 11.00M shares 10-K · filed 2014-03-17 | 10.82M shares derived: average of 2 quarters · filed 2014-03-17 | 10.55M shares derived: average of 3 quarters · filed 2014-03-17 | 10.20M shares derived: average of 4 quarters · filed 2014-03-17 | |
| 2011-12-31 | 10.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | 10.33M shares derived: average of 2 quarters · filed 2014-03-17 | 9.94M shares derived: average of 3 quarters · filed 2014-03-17 | 9.71M shares 10-K · filed 2014-03-17 | |
| 2011-09-30 | 10.02M shares 10-Q · filed 2012-11-14 | 9.58M shares derived: average of 2 quarters · filed 2012-11-14 | 9.40M shares 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | 9.15M shares 10-Q · filed 2012-08-14 | 9.09M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |